H. Inoue

Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: a retrospective multicenter cohort study

H. Nagano, J. Furuse, H. Imaoka, 2020, BMC cancer.

Risk stratification and prognostic factors in patients with unresectable undifferentiated carcinoma of the pancreas.

J. Furuse, H. Imaoka, M. Ikeda, 2021, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Pre-treatment tumor size impacts on response to nivolumab in head and neck squamous cell carcinoma.

A. Notsu, T. Onitsuka, H. Yasui, 2020, Auris, nasus, larynx.

Correction to: Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer

M. Endo, H. Kenmotsu, T. Naito, 2020, Investigational New Drugs.

Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer

M. Endo, H. Kenmotsu, T. Naito, 2020, Investigational New Drugs.

Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer

H. Yasui, T. Tsushima, K. Yamazaki, 2021, Investigational New Drugs.

Feasibility and efficacy of chemoradiotherapy with concurrent split‐dose cisplatin after induction chemotherapy with docetaxel/cisplatin/5‐fluorouracil for

T. Onitsuka, Y. Onozawa, T. Yokota, 2020 .